These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24348021)

  • 1. P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
    Ma A; Wang C; Chen Y; Yuan W
    Drug Des Devel Ther; 2013; 7():1447-54. PubMed ID: 24348021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats.
    Ferreira A; Rodrigues M; Meirinho S; Fortuna A; Falcão A; Alves G
    Drug Chem Toxicol; 2021 Sep; 44(5):458-469. PubMed ID: 31020859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats.
    Potschka H; Löscher W
    Epilepsia; 2001 Oct; 42(10):1231-40. PubMed ID: 11737157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR1 gene expression in brain of patients with medically intractable epilepsy.
    Tishler DM; Weinberg KI; Hinton DR; Barbaro N; Annett GM; Raffel C
    Epilepsia; 1995 Jan; 36(1):1-6. PubMed ID: 8001500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain.
    Potschka H; Fedrowitz M; Löscher W
    Neuroreport; 2001 Nov; 12(16):3557-60. PubMed ID: 11733711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.
    Rizzi M; Caccia S; Guiso G; Richichi C; Gorter JA; Aronica E; Aliprandi M; Bagnati R; Fanelli R; D'Incalci M; Samanin R; Vezzani A
    J Neurosci; 2002 Jul; 22(14):5833-9. PubMed ID: 12122045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.
    Potschka H; Fedrowitz M; Löscher W
    Neurosci Lett; 2002 Jul; 327(3):173-6. PubMed ID: 12113905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats.
    Potschka H; Volk HA; Löscher W
    Neuroreport; 2004 Jul; 15(10):1657-61. PubMed ID: 15232302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats.
    Chen YH; Wang CC; Xiao X; Wei L; Xu G
    Acta Pharmacol Sin; 2013 Apr; 34(4):473-9. PubMed ID: 23474709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
    Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
    Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats.
    Shao Y; Wang C; Hong Z; Chen Y
    J Neurochem; 2016 Mar; 136(5):1096-105. PubMed ID: 26677173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.
    Potschka H; Löscher W
    Neuroreport; 2001 Aug; 12(11):2387-9. PubMed ID: 11496115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocage encapsulation improves antiepileptic efficiency of phenytoin.
    Zhao J; Ye Z; Yang J; Zhang Q; Shan W; Wang X; Wang Z; Ye S; Zhou X; Shao Z; Ren L
    Biomaterials; 2020 May; 240():119849. PubMed ID: 32087458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
    Potschka H; Fedrowitz M; Löscher W
    Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of "spasmolytic powder" on pgp expression of Coriaria Lactone-kindling drug-resistant epileptic rat model.
    Chen L; Feng P; Li Y; Zhou D
    J Mol Neurosci; 2013 Sep; 51(1):1-8. PubMed ID: 23263794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions.
    Seegers U; Potschka H; Löscher W
    Eur J Pharmacol; 2002 Sep; 451(2):149-55. PubMed ID: 12231384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.